Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10613327 | Journal of Controlled Release | 2005 | 11 Pages |
Abstract
Probably due to the influence of the skin perm-selectivity and the competition with H+, increase in pH from 3 to 5 resulted in a significant increase in flux. Further increase in pH to 6 did not further increase the flux. The iontophoretic transport was found to increase linearly with concentration and current density, providing a convenient way to manage dose titration for Parkinson's disease therapy. Increase in concentration of NaCl dramatically reduced the flux of 5-OH-DPAT as a result of ion competition to the transport. When DHS was used, the iontophoretic transport was less. Also, with DHS the response in flux profile, by switching the current on and off, was shallower than that with HSC. With the optimum condition, a delivery of 104 μg of 5-OH-DPAT per cm2 patch per hour is feasible, indicating that the therapeutic level could be achieved with a smaller patch size than required in case of rotigotine. Thus, based on this in vitro study, transdermal iontophoretic delivery of 5-OH-DPAT is very promising.
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Akhmad Kharis Nugroho, Li Li, Durk Dijkstra, HÃ¥kan Wikström, Meindert Danhof, Joke A. Bouwstra,